Maintenance avelumab therapy for urothelial carcinoma in a hemodialysis patient: a case report
Maintenance avelumab therapy for urothelial carcinoma in a hemodialysis patient: a case report
About this item
Full title
Author / Creator
Publisher
Singapore: Springer Nature Singapore
Journal title
Language
English
Formats
Publication information
Publisher
Singapore: Springer Nature Singapore
Subjects
More information
Scope and Contents
Contents
In recent years, immune checkpoint inhibitors have attracted attention in treatment for urothelial carcinoma. However, many clinical trials included only patients who had adequate renal function. The efficacy of immune checkpoint inhibitors for hemodialysis patients had not been well-documented. Herein, we report a case of a 73-years-old male with...
Alternative Titles
Full title
Maintenance avelumab therapy for urothelial carcinoma in a hemodialysis patient: a case report
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10764676
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10764676
Other Identifiers
ISSN
2192-3183
E-ISSN
2192-3183
DOI
10.1007/s13691-023-00636-4
